Related by context. All words. (Click for frequent words.) 71 Overactive Bladder 70 Chronic Myeloid Leukemia 69 Crohn Disease 69 Severe Asthma 68 Generalized Anxiety Disorder 68 Complicated Skin 68 Lupus Nephritis 68 Leukemias 67 Myelodysplastic Syndromes 67 Rheumatoid Arthritis 67 Knee Osteoarthritis 67 Investigational Treatment 67 Atopic Dermatitis 67 Cutaneous T 67 Allergic Rhinitis 67 Psychiatric Disorders 66 Chronic Lymphocytic Leukemia 66 Diabetic Patients 66 Irritable Bowel Syndrome IBS 66 Autoimmune Diseases 66 Disease Progression 66 Inflammatory Markers 66 Renal Cell Carcinoma 66 Chronic Sinusitis 66 Allergic Asthma 66 Stomach Cancer 66 HER2 Positive Breast Cancer 65 Rheumatoid Arthritis Patients 65 Major Depressive Disorder 65 Bladder Cancer 65 Newly Diagnosed 65 Breast Cancer Recurrence 65 Pediatric Patients 65 Hypercholesterolemia 65 Enlarged Prostate 65 Disease IBD 65 Advanced Melanoma 65 Diabetic Nephropathy 65 Treatment Naive Patients 65 Hepatocellular Carcinoma 65 Prophylactic Treatment 65 Slow Progression 65 Phase IIb Trial 65 Postmenopausal Women 64 Antitumor Activity 64 Myelofibrosis 64 Treatment Shows Promise 64 Gene Mutation 64 Renal Function 64 Rheumatoid Arthritis RA 64 Insulin Resistance 64 Postherpetic Neuralgia 64 Metastatic Colorectal Cancer 64 Panic Disorder 64 Relapsed Refractory Aggressive 64 Chronic Constipation 64 Limb Ischemia 64 Gene Linked 64 Crohn disease 64 Bevacizumab 64 Malignant Melanoma 64 Cell Lymphoma 64 Relapsing Remitting Multiple Sclerosis 64 Meets Primary Endpoint 64 Subgroup Analysis 64 Phase 2b Study 64 Unresectable 64 ulcerative colitis 64 Combination Treatment 64 Short Stature 64 Combination Therapy 64 Diabetic Neuropathy 64 Treating Chronic 64 Mouse Model 64 Esophagitis 64 Growth Hormone Deficiency 64 Pooled Analysis 64 Dupuytren Contracture 64 Patients Suffering 64 Systemic lupus erythematosus SLE 63 Menopausal Women 63 Pulmonary Arterial Hypertension 63 Hormone Refractory Prostate Cancer 63 Genetic Variant 63 Bipolar Depression 63 Chronic Bronchitis 63 complement inhibitor eculizumab 63 Aggressive Prostate Cancer 63 Drug Resistant 63 Advanced Renal Cell 63 Treatment Resistant 63 Gum Disease 63 Migraine Headaches 63 Psoriasis Patients 63 Oral Fingolimod 63 Gene Variant 63 Squamous 63 Juvenile Idiopathic Arthritis 63 Adjuvant Chemotherapy 63 Autoimmune Disorders 63 Social Anxiety Disorder 63 Phase 2b Trial 63 Eosinophilic 63 Heart Failure Patients 63 Bronchiectasis 63 Glioblastoma Multiforme 63 Phase 2b Clinical Trial 63 Mantle Cell Lymphoma 63 ACE Inhibitors 63 Acute Myeloid Leukemia 63 Previously Treated 63 lupus erythematosus 63 Adalimumab 63 Kidney Stones 63 Clinical Trial Results 63 Improves Outcomes 63 Adjuvant Treatment 63 Bosutinib 63 Angioedema 63 Irritable Bowel 63 Aortic Stenosis 63 Resistant Hypertension 63 Viral Infection 63 Idiopathic Pulmonary Fibrosis 63 Systemic Sclerosis 63 Urinary Incontinence 63 Phase III Trial 63 Antifungals 63 Chronic Hepatitis B 63 Chronic Myelogenous Leukemia 63 Generalized Anxiety Disorder GAD 63 Gastric Cancer 63 Metastatic Prostate Cancer 63 Treated Patients 63 Genetic Disorder 62 Social Phobia 62 Inflammatory Bowel Disease 62 Benign Prostatic Hyperplasia 62 Chronic HCV 62 Elderly Patients 62 Septic Shock 62 Chronic Cough 62 Bacterial Infections 62 Cimzia ® certolizumab pegol 62 Bacterial Vaginosis 62 Prospective Randomized 62 Improve Survival 62 Psoriatic Arthritis 62 JAK Inhibitor 62 Rheumatoid 62 Bipolar Mania 62 Reflux Disease 62 Treatment Regimen 62 Drug Candidate 62 Statistically Significant 62 Drug Pipeline 62 Diagnostic Criteria 62 Chronic Pelvic Pain 62 Suicidality 62 Golimumab 62 Hepatitis C Virus 62 Key Attributes 62 Effectively Treats 62 Systemic Lupus Erythematosus 62 Dyslipidemia 62 Drug Shows Promise 62 Patients Treated With 62 Glioma 62 Liver Metastases 62 Severe Primary IGFD 62 Genetic Mutation 62 Treatable 62 Genital Herpes 62 Myelodysplastic Syndrome 62 Effective Treatments 62 Genetic Mutations 62 Unfractionated Heparin 62 Drug Prevents 62 Adenocarcinoma 62 Transdermal Patch 62 Emerging Therapies 62 Follicular Lymphoma 62 Improved Survival 62 Advanced Prostate Cancer 62 Decitabine 62 Chronic Hepatitis C 62 Ofatumumab 62 Monotherapy 62 Mitral Regurgitation 62 Acute Myelogenous Leukemia 62 Mucositis 62 Chronic Heart Failure 62 Fabry Disease 62 Genes Associated 62 Epilepsy Drug 62 Prolongs Survival 62 Soft Tissue Sarcoma 62 Diabetic Neuropathic Pain 62 Gastric Ulcer 62 Anthracycline 62 Phase IIb Clinical Trial 62 Nerve Pain 62 Breast Cancers 62 Ischemic Stroke 62 HeFH 62 Immunosuppressant 62 Diuretic 62 Severe Acne 62 Nonalcoholic Fatty Liver Disease 62 Chronic Inflammation 62 debilitating autoimmune 62 Patients Receiving 62 Plaque Psoriasis 62 leukemia AML 62 Iron Overload 62 Epratuzumab 62 Study Evaluating 62 Novel Oral 62 Serious Infections 62 Squamous Cell Carcinoma 62 Relapsed Refractory 62 B Cell Lymphoma 62 Chronic lymphocytic leukemia 62 Respiratory Distress 62 Survival Benefit 62 Refractory Hodgkin Lymphoma 62 Organ Rejection 61 Investigational Drug 61 homozygous familial hypercholesterolemia 61 Lymphomas 61 Epidermal Growth Factor Receptor 61 Safinamide 61 Etanercept 61 Chronic Lymphocytic Leukemia CLL 61 Myelodysplastic Syndrome MDS 61 rheumatic disease 61 Autoimmune Disease 61 Anti TNF 61 Medulloblastoma 61 T Cell Lymphoma 61 Acute Leukemia 61 Psoriatic arthritis 61 Gastrointestinal Disorders 61 Gene Mutations 61 Peripheral Artery Disease 61 Invasive Breast Cancer 61 Cardiovascular Outcomes 61 STELARA TM 61 mastocytosis 61 Renal Impairment 61 Combo Therapy 61 Cold Sores 61 Acute Pancreatitis 61 Aliskiren 61 Portal Hypertension 61 Radiofrequency Ablation 61 Advanced Pancreatic Cancer 61 Premenopausal Women 61 Kidney Failure 61 Fungal Infections 61 Breast Cancer Metastasis 61 Virus Linked 61 Gliomas 61 Breast Tumors 61 CIDP 61 Relapsing Multiple Sclerosis 61 Breast Cancer Treatment 61 Phase III Clinical Trial 61 Naive Patients 61 Stem Cell Treatment 61 Migraine Pain 61 Cognitive Impairment 61 Non Alcoholic Fatty 61 Multiple Myeloma Patients 61 Progenitor Cells 61 Demonstrates Efficacy 61 Osteoporosis Drugs 61 invasive candidiasis 61 Novel Treatments 61 von Willebrand Disease 61 Liver Failure 61 Skin Condition 61 Cancer Treatments 61 Metastases 61 MPS VI 61 Onychomycosis 61 Rhinitis 61 Hyperkalemia 61 Bosentan 61 Fludarabine 61 Skin Cancers 61 fibromyalgia syndrome 61 Phase 2a Clinical Trial 61 Juvenile Idiopathic Arthritis JIA 61 Randomized Study 61 systemic lupus erythematosus psoriasis 61 Proves Effective 61 Hip Fractures 61 Tumor Growth 61 Immune Mediated 61 Hemodialysis Patients 61 Metastatic Renal Cell Carcinoma 61 Genes Linked 61 Severe Sepsis 61 Chronic Myeloid Leukemia CML 61 Skin Structure Infections 61 Ulcerative colitis 61 Physician Insights 61 Colorectal Cancer Patients 61 arthritis PsA 61 vWD 61 disease GERD 61 Hepatitis C Genotype 61 Diabetic Macular Edema 61 cell lymphoma CTCL 61 Asthma COPD 61 primary Restless Legs 61 Beta Blocker 61 Prostate Cancer Patients 61 FDA Okays 61 Investigational Agent 61 Blood Pressure Drug 61 chronic eosinophilic leukemia 61 Community Acquired Pneumonia 61 Erectile Dysfunction Drug 61 Chronic Inflammatory 61 Hyperlipidemia 61 Improves Survival 61 Hormone Receptor Positive 61 Anticoagulants 61 Dapagliflozin 61 Atypical Hemolytic Uremic Syndrome 61 Rare Genetic 61 Neuropathic Pain 61 Beta Blockers 61 Well Tolerated 60 Cell Lung Cancer 60 atypical Hemolytic Uremic Syndrome 60 Genetic Variation 60 Artery Disease 60 Previously Untreated 60 Cardiovascular Events 60 Cimzia TM 60 Atypical Antipsychotics 60 Morquio 60 acute porphyria 60 Appears Safe 60 Dasatinib 60 Inflammatory Diseases 60 Shows Efficacy 60 Comorbid 60 purpura ITP 60 Surgical Treatment 60 Ischemic 60 Patient Outcomes 60 Newly Diagnosed Multiple Myeloma 60 Blood Clots 60 juvenile idiopathic arthritis 60 Carcinoma 60 Endometrial Cancer 60 Esophageal Cancer 60 Tiotropium 60 Irritable Bowel Syndrome 60 Myeloma Patients 60 Pivotal Study 60 Investigational Compound 60 Bipolar Disorder 60 Crohn disease CD 60 Clostridium difficile Infection 60 Lung Cancer Patients 60 Genetic Variations 60 Parnate 60 Hepatic Encephalopathy 60 relapsing multiple sclerosis 60 Neuroendocrine Tumors 60 Preclinical Models 60 Orthostatic Hypotension 60 Increased Mortality 60 Cholesterol Levels 60 osteoporotic vertebral fractures 60 Inhaled Corticosteroids 60 Disease Modification 60 hypereosinophilic syndrome 60 systemic juvenile idiopathic 60 Disease Modifying 60 Pharmacokinetic Study 60 Long Term Efficacy 60 Tezampanel 60 Irinotecan 60 Thiazolidinediones 60 Therapy Shows Promise 60 Diabetic Foot Ulcers 60 Hemolysis 60 Anticancer Activity 60 Insulin Delivery 60 Polycystic Ovary Syndrome 60 Schizoaffective Disorder 60 Phase III Trials 60 Benign Prostatic Hyperplasia BPH 60 Slows Progression 60 FASLODEX 60 PEGylated Fab fragment 60 AAT Deficiency 60 Breast Cancer Patients 60 inflammatory bowel diseases 60 Acute Coronary Syndromes 60 Estrogen Therapy 60 Pulmonary Hypertension 60 Receives Orphan Drug Designation 60 Acute Attacks 60 Alemtuzumab 60 Kepivance 60 Dialysis Patients 60 Respiratory Infections 60 Nymox NX 60 Hepatitis C Infection 60 Fracture Risk 60 Seasonal Allergic Rhinitis 60 Genital Warts 60 Meta Analysis 60 Chemotherapeutic Agents 60 Non Hodgkin 60 Metastatic Melanoma 60 ankylosing spondylitis AS 60 Renal Cancer 60 Patient Enrollment 60 Alequel 60 Renal Anemia 60 Metabolic Disorder 60 Ankylosing spondylitis 60 Nilotinib 60 Anticancer Drugs 60 Patients Treated 60 Lipodystrophy 60 adalimumab Humira 60 Interferon Beta 60 Restless Legs Syndrome RLS 60 Rheumatoid Arthritis Drug 60 Lymphoid 60 Liver Damage 60 Protein Linked 60 Exacerbations 60 IBS C 60 Hepatitis B Virus 60 Muscle Pain 60 constipation OIC 60 Uterine Fibroids 60 Acute Heart Failure 60 ST Elevation Myocardial 60 Phase 2a Trial 60 Gene Variants 60 Fibromyalgia Pain 60 Neoplasms 60 Acute Renal Failure 60 Hashimoto thyroiditis 60 Acute Exacerbations 60 Lowers Risk 60 Peptic Ulcer 60 PsA 60 Anaplastic 60 Infected Patients 60 Drug Combo 60 Receives Positive Opinion 60 Ustekinumab 60 Chronic Insomnia 60 Trigeminal Neuralgia 60 Eltrombopag 60 Epstein Barr Virus 60 Neurodegenerative 60 Peripheral Neuropathy 60 Bowel Disease 60 LHON 60 Multicenter Trial 60 Thromboembolic 60 Lung Tumors 60 inflammatory demyelinating 60 Peginterferon 60 Thyroid Cancer 60 myeloproliferative neoplasms 60 Blood Cancers 60 Ranolazine 60 Study Showed 60 Cholesterol Lowering Drug 60 Idiopathic 60 See CLINICAL PHARMACOLOGY 60 Hemorrhagic Stroke 60 Tyrosine Kinase Inhibitor 59 Natalizumab 59 Pneumococcal Vaccine 59 Potent Anti 59 Venous Thromboembolism 59 Vasculitis 59 Hepatitis C Patients 59 Progressive Multifocal Leukoencephalopathy 59 Adenomas 59 Anti Clotting Drug 59 Respiratory Syncytial Virus 59 Hyperuricemia 59 Hypertensive Patients 59 Sjogren Syndrome 59 Gestational Diabetes 59 overactive bladder symptoms 59 Efficacious 59 retinal vein occlusion 59 Vitro Activity 59 Inflammatory Bowel Diseases 59 Antiviral Therapy 59 Single Dose 59 Critical Limb Ischemia CLI 59 Fingolimod 59 Fewer Side Effects 59 Cancer Recurrence 59 Castration Resistant Prostate Cancer 59 Thromboembolism 59 Monoclonal Antibody 59 Periodontitis 59 Treatment Reduces 59 Chronic Fatigue Syndrome CFS 59 Ankylosing Spondylitis 59 Gene Therapy Trial 59 Critical Limb Ischemia 59 Blocked Arteries 59 Carcinomas 59 Improve Outcomes 59 lichen planus 59 Acute Bacterial Skin 59 Obesity Linked 59 Autologous Stem Cell Transplantation 59 Iron Deficiency 59 Liver Injury 59 Platinol ® 59 Adenoma 59 Kidney Transplant Patients 59 Partial Onset Seizures 59 Statin Drugs 59 Lymphocytic 59 Lenalidomide 59 metastatic malignant 59 Mouse Models 59 Brain Atrophy 59 Secondary Hyperparathyroidism 59 Diabetes Hypertension 59 ulcerative colitis Crohn disease 59 PEGylated interferon beta 1a 59 Colorectal Cancer Risk 59 hepatocellular cancer 59 FDA Approves Drug 59 Carotid Stenting 59 Randomized Double Blind 59 angioedema 59 Novel Mechanism 59 Polycystic ovary syndrome PCOS 59 NDA Submission 59 Non Hodgkin Lymphoma 59 Treatment Options 59 subependymal giant cell 59 efalizumab 59 Initiate Clinical Trial 59 Thrombocytopenia 59 Anti Tumor 59 Predict Risk 59 Genes Predict 59 Completes Patient Enrollment 59 Not Otherwise Specified 59 GABITRIL 59 Chemokine Receptor 59 Contrast Agent 59 systemic lupus erythematosus 59 Corticosteroids 59 Plus Ribavirin 59 Anticoagulant 59 Chronic Prostatitis 59 Tocilizumab 59 ST Segment Elevation 59 Hepatocellular Carcinoma HCC 59 Bortezomib 59 Fondaparinux 59 Is Well Tolerated 59 Paraplatin ® 59 HBeAg negative 59 Stable Coronary Artery 59 Peritonitis 59 Aflibercept 59 Essential Tremor 59 Premature Aging 59 Urinary Tract Infections 59 Pivotal Phase 59 proliferative diabetic retinopathy 59 Abdominal Pain 59 Malignancies 59 Acute Promyelocytic Leukemia 59 mycophenolate mofetil 59 Shows Promise Against 59 Kit CD# positive 59 Candidiasis 59 Basal Cell Carcinoma 59 TNF Blockers 59 Experimental Vaccine 59 erythematosus 59 Statin Therapy 59 Gene Variation 59 gastrointestinal stromal tumors GIST 59 Bone Marrow Cells 59 Bone Fracture 59 Brain Metastases 59 Philadelphia Chromosome Positive 59 DPNP 59 Lupus Drug 59 Female Sexual Arousal 59 Often Misdiagnosed 59 NASH Huntington 59 Brentuximab Vedotin SGN 59 Brain Tumors 59 Combination REOLYSIN R 59 Commonly Used 59 Controlled Trial 59 Fluorouracil 59 Acid Reflux 59 Pregabalin 59 Gout Drug 59 Therapeutic Vaccine 59 Varicose Veins 59 Systemic Lupus Erythematosus SLE 59 Primary Biliary Cirrhosis 59 Lubiprostone 59 Heterozygous Familial Hypercholesterolemia 59 Immunotherapeutic 59 Sinus Infections 59 Recombinant Human 59 Gaucher Disease 59 Patients Undergoing 59 Nonalcoholic fatty liver 59 post herpetic 59 Paroxysmal Nocturnal Hemoglobinuria PNH 59 Parkinsonian Syndromes 59 Schizophrenia Drug 59 Antipsychotic Drugs 59 Thyroid Disease 59 Pivotal Trial 59 Traficet EN 59 Anti Nausea 59 Pfizer Lyrica 59 Neural Stem Cells 59 gastro esophageal reflux 59 Leber Hereditary Optic Neuropathy 59 Phase III Pivotal 59 Gastroesophageal Reflux Disease 59 Subtypes 59 Skin Lesions 59 Breast Cancer Cells 59 RhuDex 59 Osteosarcoma 59 Omalizumab 59 Iron Deficiency Anemia 59 B Cell Malignancies 59 Vulvar 59 Microalbuminuria 59 candidiasis 59 Embolization 59 sJIA 59 Sudden Cardiac Death 59 Skeletal Muscle 59 Prolongs Life 59 Pulmonary Arterial Hypertension PAH 59 Therapy Evaluation 59 Genes Identified 59 Maven Semantic 59 Intracerebral Hemorrhage 59 Vaccine Candidate 59 FDA Accepts 59 anterior uveitis 59 CTAP# Capsules 59 Glufosfamide 59 Multiple sclerosis MS 59 Polyneuropathy 59 Autoimmune 59 Pain Medications 58 postherpetic neuralgia 58 rheumatoid arthritis osteoarthritis ankylosing 58 Lung Cancers 58 Glucose Metabolism 58 Nocturia 58 Lennox Gastaut Syndrome 58 Degarelix 58 Acute Myelogenous Leukemia AML 58 Pancreatic Cancer 58 Oral Mucositis 58 Rifaximin 58 Sinusitis 58 Myopathy 58 Dose Escalation 58 COPAXONE R 58 Symptom Relief 58 Prostate Cancers 58 Diabetic Foot Ulcer 58 Sleep Disturbances 58 Novel Compound 58 Thrombotic 58 Stakeholder Opinions 58 Genotypes 58 Chronic Rhinosinusitis 58 Risk Stratification 58 Asthma Attacks 58 Chemotherapy induced 58 metastatic neuroendocrine tumors 58 Node Positive 58 hyperphenylalaninemia HPA due 58 Parkinson Disease PD 58 Antipsychotic Drug 58 Antihistamine 58 Small Intestine 58 Randomized Phase 58 Cervical Dystonia 58 Virus Infection 58 Salmeterol 58 Adjunctive Therapy 58 Diabetic Retinopathy 58 Stem Cell Transplants 58 Benign prostatic hyperplasia BPH 58 Carbamazepine 58 Inhaled Liposomal Ciprofloxacin 58 Enzastaurin 58 Dalbavancin 58 Migraine Headache 58 Left Ventricular Hypertrophy 58 dyskinesia PD LID 58 Osteoporosis Treatment 58 ADPKD 58 chronic immune thrombocytopenic 58 Inflammatory Disease 58 Cognitive Deficits 58 Clinical Efficacy 58 post herpetic neuralgia PHN 58 lysosomal storage disease 58 Targeted Therapy 58 Gastric Bypass Surgery 58 Unstable Angina 58 tuberous sclerosis TS 58 Arrhythmogenic 58 Malignant Glioma 58 Lung Cancer Drug 58 Eculizumab 58 thalidomide Thalomid 58 Phenotype 58 overactive bladder syndrome 58 autoimmune thyroid 58 Anti Tumor Activity 58 gastrointestinal stromal tumor GIST 58 Ovarian Cancer Patients 58 Therapeutic Potential 58 Acute myeloid leukemia 58 gastro esophageal reflux disease 58 Adjuvant Therapy 58 Metastatic breast cancer 58 Advanced Colorectal Cancer 58 Keratitis 58 haloperidol Haldol 58 Antiangiogenic 58 Therapeutic Efficacy 58 Bulimia Nervosa 58 Metastatic 58 Stakeholder Insight 58 Peanut Allergy 58 CYT# potent vascular disrupting 58 Tolerability 58 psoriatic arthritis PsA 58 Factor Receptor 58 Neovascular Age Related Macular 58 Prostate Cancer Treatment 58 Kidney Function 58 Demonstrates Positive 58 eosinophilic asthma 58 Radiofrequency Ablation RFA 58 gastrointestinal reflux 58 invasive aspergillosis 58 Colorectal Adenomas 58 Anticonvulsants 58 Arterial Disease 58 tigecycline 58 aripiprazole Abilify 58 Genetic Disorders 58 Knee Arthritis 58 Diabetic Ulcers 58 Bronchodilator 58 Kinase Inhibitors 58 Artificial Pancreas 58 Intracranial Aneurysms 58 Prognostic Significance 58 Pleural Mesothelioma 58 PKU genetic 58 juvenile myoclonic epilepsy 58 diarrhea predominant irritable 58 Cardiovascular Mortality 58 SPRYCEL ® 58 Diffuse Large B 58 Valvular Heart Disease 58 Obstructive Sleep Apnoea 58 Blepharospasm 58 Fibrosis 58 atypical hemolytic uremic syndrome 58 Spinal Fusion 58 Pegylated Interferon 58 immune thrombocytopenic purpura 58 Topical Treatment 58 carcinoid tumors 58 Pervasive Developmental Disorders 58 Androgen Deprivation Therapy 58 Periodontal Disease 58 Valopicitabine 58 Pirfenidone 58 Vaccine Adjuvant 58 Pervasive Developmental Disorder 58 Comorbidities 58 leukoencephalopathy 58 chronic myeloid 58 Acid Reflux Disease 58 interferon therapy 58 AAT deficiency 58 Obstructive Sleep Apnea 58 steroid refractory ulcerative 58 bullous 58 Phase III Clinical Trials 58 Placebo Controlled Trial 58 osteosarcomas 58 Meningiomas 58 Hsp# Inhibitor 58 systemic autoimmune 58 Clinical Trial Evaluating 58 Colon Polyps 58 glitazones 58 relapsing remitting MS RRMS 58 Drug Combinations 58 Allergic Reactions 58 proctitis 58 Male Infertility 58 Ovarian Cancers 58 Basal Cell 58 debilitating complication 58 Endocarditis 58 Shows Promising 58 Cethromycin 58 Mayo Clinic Study Finds 58 Tasigna nilotinib 58 Aripiprazole 58 Treat Heart Failure 58 ANCA associated 58 Postmenopausal Osteoporosis 58 Retinitis Pigmentosa RP 58 polyarticular 58 Adrenal Fatigue 58 Controlled Study 58 situ CIS 58 Bleeding Disorder 58 Elagolix 58 TNF Tumor Necrosis Factor 58 Meningococcal Disease 58 Antibiotic Resistant 58 Glycemic Control 58 Rituximab 58 Capecitabine 58 Low Dose 58 Preterm Delivery 58 Phase IIa Clinical Trial 58 Antipsychotic 58 Therapy Improves 58 QVAR ® 58 Rhabdomyolysis 58 Clinical Outcome 58 Hormone Therapy 58 visilizumab 58 Restless Legs Syndrome 58 Prediabetes 58 Antiplatelet Therapy 58 Analytical Tool 58 Lung Cancer Survival 58 Asymptomatic 58 Ear Infections 58 Nitazoxanide 58 Oral Cavity 58 Bone Metastases 58 dermatologic reactions 58 Candida infection 58 venlafaxine Effexor 58 Less Invasive 58 polymyalgia rheumatica 58 Insulin Sensitivity 58 familial hypercholesterolemia 58 Adjuvant 58 Palifosfamide 58 Placebo Controlled Study 58 Excessive Sweating 58 Increased Risk 58 Double Blind Placebo 58 Statin Use 58 Navelbine 58 Skin Structure Infections ABSSSI 58 Vandetanib 58 Interstitial Cystitis 58 Toxicities 58 Spasticity 58 Viral Infections 58 Diarrheal 57 ISTODAX ® 57 Enbrel Humira 57 Treatment Naïve 57 Preclinical Study 57 Methotrexate 57 Demonstrates Potent 57 Xyfid TM 57 Sapacitabine 57 II Clinical Trial 57 Peyronie 57 Liver Tumors 57 Acute Myeloid Leukaemia AML 57 psoriasis rheumatoid arthritis 57 Immune Deficiency 57 SIMPONI TM 57 glatiramer acetate 57 Minimally Invasive Treatment 57 progressive neurodegenerative disorder 57 Fusarium Keratitis 57 Uterine Fibroid Embolization 57 Exercise Reduces 57 Signaling Pathway 57 Treating Heart Failure 57 Personalized Immunotherapy 57 Epileptic Seizures 57 Pemphigus Vulgaris 57 Seasonal Allergies 57 unresectable stage 57 osteoarthritis rheumatoid arthritis 57 Cardiotoxicity 57 Dyskinesia 57 Vaccine Shows Promise 57 Sipuleucel T 57 Rivastigmine 57 Bisphosphonate 57 T2DM 57 systemic lupus erythematosus SLE 57 Chronic Obstructive Pulmonary 57 Transplant Rejection 57 Yeast Infections 57 Neoadjuvant Chemotherapy 57 SHPT 57 Osteoarthritis Pain 57 rheumatoid arthritis psoriatic arthritis 57 HER2 Positive 57 Sustained Reduction 57 Pathogenesis 57 non alcoholic steatohepatitis 57 leukemia ALL 57 Brain Aneurysms 57 Irritable bowel syndrome 57 post transplant lymphoproliferative 57 Polycythemia Vera 57 NICE Recommends 57 Sustained Efficacy 57 Icatibant 57 Cognitive Decline 57 Cancer Therapies 57 Gastroparesis 57 Blood Disorder 57 GW# [003] 57 Dose Escalation Study 57 Boceprevir 57 Melasma 57 diabetic nephropathy 57 Crohns disease 57 Gluten Intolerance 57 Prognostic Factors 57 Actonel risedronate 57 chronic inflammatory bowel 57 Aviptadil 57 Novel Small Molecule 57 Romiplostim 57 Severe Psoriasis 57 SJIA 57 Alternative Treatments 57 Asthma Treatment 57 Antidepressant Use 57 Raynaud syndrome 57 Newly Diagnosed Patients 57 Bullous 57 Hepatotoxicity 57 Lymph Nodes 57 Inflammatory Arthritis 57 Pivotal Clinical Trial 57 herpes zoster shingles 57 Randomized Double blind 57 Prophylaxis 57 Non Alcoholic Steatohepatitis 57 Chronic Lung 57 Hyperplasia 57 Non Invasive Treatment 57 Hypertrophy 57 vaginal yeast infections 57 Catheter Associated 57 primary hypercholesterolemia 57 hypercholesterolaemia